- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.75 Å
- Oligo State
- hetero-3-3-mer
- Ligands
- 3 x NAG- NAG- BMA- MAN- MAN: alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 3 x NAG- NAG- BMA: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
NAG-NAG-BMA.2: 6 residues within 4Å:- Chain A: N.159, I.236
- Chain C: S.213, P.215, R.216
- Ligands: NAG.7
3 PLIP interactions:2 interactions with chain C, 1 interactions with chain A- Hydrogen bonds: C:R.216
- Water bridges: C:R.216
- Hydrophobic interactions: A:I.236
NAG-NAG-BMA.11: 6 residues within 4Å:- Chain C: N.159, I.236
- Chain E: S.213, P.215, R.216
- Ligands: NAG.16
3 PLIP interactions:1 interactions with chain C, 2 interactions with chain E- Hydrophobic interactions: C:I.236
- Hydrogen bonds: E:R.216
- Water bridges: E:R.216
NAG-NAG-BMA.20: 6 residues within 4Å:- Chain A: S.213, P.215, R.216
- Chain E: N.159, I.236
- Ligands: NAG.25
3 PLIP interactions:1 interactions with chain E, 2 interactions with chain A- Hydrophobic interactions: E:I.236
- Hydrogen bonds: A:R.216
- Water bridges: A:R.216
- 3 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
NAG-NAG.3: 5 residues within 4Å:- Chain A: S.39, N.279, V.291, N.292
- Chain B: E.69
No protein-ligand interaction detected (PLIP)NAG-NAG.12: 5 residues within 4Å:- Chain C: S.39, N.279, V.291, N.292
- Chain D: E.69
No protein-ligand interaction detected (PLIP)NAG-NAG.21: 5 residues within 4Å:- Chain E: S.39, N.279, V.291, N.292
- Chain F: E.69
No protein-ligand interaction detected (PLIP)- 15 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
NAG.4: 3 residues within 4Å:- Chain A: N.16, T.18, T.31
2 PLIP interactions:2 interactions with chain A- Hydrogen bonds: A:N.16
- Water bridges: A:N.32
NAG.5: 3 residues within 4Å:- Chain A: E.56, N.57, Y.88
3 PLIP interactions:3 interactions with chain A- Hydrogen bonds: A:N.57, A:Y.88
- Water bridges: A:N.57
NAG.6: 1 residues within 4Å:- Chain A: N.127
1 PLIP interactions:1 interactions with chain A- Hydrogen bonds: A:N.127
NAG.7: 8 residues within 4Å:- Chain A: A.157, L.158, N.159, R.195, N.240, S.241, T.242
- Ligands: NAG-NAG-BMA.2
1 PLIP interactions:1 interactions with chain A- Water bridges: A:T.242
NAG.9: 4 residues within 4Å:- Chain B: A.147, G.150, S.151, N.154
1 PLIP interactions:1 interactions with chain B- Hydrogen bonds: B:N.154
NAG.13: 3 residues within 4Å:- Chain C: N.16, T.18, T.31
2 PLIP interactions:2 interactions with chain C- Hydrogen bonds: C:N.16
- Water bridges: C:N.32
NAG.14: 3 residues within 4Å:- Chain C: E.56, N.57, Y.88
3 PLIP interactions:3 interactions with chain C- Hydrogen bonds: C:N.57, C:Y.88
- Water bridges: C:N.57
NAG.15: 1 residues within 4Å:- Chain C: N.127
1 PLIP interactions:1 interactions with chain C- Hydrogen bonds: C:N.127
NAG.16: 8 residues within 4Å:- Chain C: A.157, L.158, N.159, R.195, N.240, S.241, T.242
- Ligands: NAG-NAG-BMA.11
1 PLIP interactions:1 interactions with chain C- Water bridges: C:T.242
NAG.18: 4 residues within 4Å:- Chain D: A.147, G.150, S.151, N.154
1 PLIP interactions:1 interactions with chain D- Hydrogen bonds: D:N.154
NAG.22: 3 residues within 4Å:- Chain E: N.16, T.18, T.31
2 PLIP interactions:2 interactions with chain E- Hydrogen bonds: E:N.16
- Water bridges: E:N.32
NAG.23: 3 residues within 4Å:- Chain E: E.56, N.57, Y.88
3 PLIP interactions:3 interactions with chain E- Hydrogen bonds: E:N.57, E:Y.88
- Water bridges: E:N.57
NAG.24: 1 residues within 4Å:- Chain E: N.127
1 PLIP interactions:1 interactions with chain E- Hydrogen bonds: E:N.127
NAG.25: 8 residues within 4Å:- Chain E: A.157, L.158, N.159, R.195, N.240, S.241, T.242
- Ligands: NAG-NAG-BMA.20
1 PLIP interactions:1 interactions with chain E- Water bridges: E:T.242
NAG.27: 4 residues within 4Å:- Chain F: A.147, G.150, S.151, N.154
1 PLIP interactions:1 interactions with chain F- Hydrogen bonds: F:N.154
- 3 x SIA: N-acetyl-alpha-neuraminic acid(Non-covalent)
SIA.8: 10 residues within 4Å:- Chain A: Y.92, G.128, T.129, S.130, S.131, N.139, W.147, D.184, L.188, S.222
6 PLIP interactions:6 interactions with chain A- Hydrogen bonds: A:T.129, A:S.131, A:N.139, A:S.222, A:S.222
- Water bridges: A:T.129
SIA.17: 10 residues within 4Å:- Chain C: Y.92, G.128, T.129, S.130, S.131, N.139, W.147, D.184, L.188, S.222
6 PLIP interactions:6 interactions with chain C- Hydrogen bonds: C:T.129, C:S.131, C:N.139, C:S.222, C:S.222
- Water bridges: C:T.129
SIA.26: 10 residues within 4Å:- Chain E: Y.92, G.128, T.129, S.130, S.131, N.139, W.147, D.184, L.188, S.222
6 PLIP interactions:6 interactions with chain E- Hydrogen bonds: E:T.129, E:S.131, E:N.139, E:S.222, E:S.222
- Water bridges: E:T.129
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Wu, N.C. et al., A structural explanation for the low effectiveness of the seasonal influenza H3N2 vaccine. PLoS Pathog. (2017)
- Release Date
- 2017-10-18
- Peptides
- Hemagglutinin HA1 chain: ACE
Hemagglutinin HA2 chain: BDF - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AC
AE
AB
BD
BF
B
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.75 Å
- Oligo State
- hetero-3-3-mer
- Ligands
- 3 x NAG- NAG- BMA- MAN- MAN: alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 3 x NAG- NAG- BMA: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 3 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 15 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 3 x SIA: N-acetyl-alpha-neuraminic acid(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Wu, N.C. et al., A structural explanation for the low effectiveness of the seasonal influenza H3N2 vaccine. PLoS Pathog. (2017)
- Release Date
- 2017-10-18
- Peptides
- Hemagglutinin HA1 chain: ACE
Hemagglutinin HA2 chain: BDF - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AC
AE
AB
BD
BF
B